WeightWatchers (WW) is trying to save its ailing business by betting on a market that threatens its very existence. The ...

WeightWatchers will begin selling compounded alternatives to certain weight-loss drugs that are experiencing shortages. Why ...

In response to rising demand for weight loss medications, WeightWatchers has launched a low-cost alternative to ...

High demand has created a market for compounded versions of the drug best known as Ozemic or Wegovy, but doctors and the FDA ...

With the addition of compounded semaglutide [GLP-1], we are expanding our offering to include a clinical weight management ...

WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say ...

WW International (NASDAQ:WW), more commonly known as WeightWatchers, will now offer compounded semaglutide to its ...

WEIGHT WATCHERS SAYS IT WILL NOW OFFER ELIGIBLE MEMBERS COMPOUNDED ... It's part of a class of drugs known as GLP-1 receptor ...

WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today the addition of compounded semaglutide into its offering, broadening eligible members’ access to clinical weight ...

Shares of WeightWatchers (WW) are climbing after the company announced a compounded GLP-1 medication starting at $129 as it ...

WeightWatchers stock rises after the company announces compounded semaglutide offerings, addressing GLP-1 shortages while ...

WeightWatchers (WW) announced Tuesday that it is now offering off-brand weight loss drugs for one of the cheapest prices in ...